Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib
抑制 AKR1B10 介导的柔红霉素代谢是 Bcr-Abl 酪氨酸激酶抑制剂达沙替尼的一种新型脱靶效应
期刊:Biochemical Pharmacology
影响因子:5.3
doi:10.1016/j.bcp.2021.114710
Neslihan Büküm, Eva Novotná, Anselm Morell, Jana Želazková, Lenka Laštovičková, Lucie Čermáková, Ramon Portillo, Petr Solich, Vladimír Wsól
